| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Unit on Genetics and Endocrinology (C.A.S., A.L., S.E.T., R.I.G.) and Unit on Growth and Development (R.I.G.), Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1862; and Institute of Molecular and Human Genetics, Georgetown University Medical Center (J.M.M., J.B.), Washington, D.C. 20007-2197
Address all correspondence and requests for reprints to: Constantine A. Stratakis, M.D., Unit on Genetics and Endocrinology, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive, MSC1862, Bethesda, Maryland 20892-1862. E-mail: stratakc{at}cc1.nichd.nih.gov
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although trisomy 16 accounts for 15% of all chromosomally abnormal abortuses and for 29% of all autosomal trisomies (8), whole or partial trisomy 16 is rarely observed in liveborn or older children and adults (9, 10, 11, 12). Duplication of the heterochromatic region 16q11-q12 is probably without clinical significance, but duplication of large regions of the long arm of chromosome 16 (from 16q13 to qter) result in severe malformations and early lethality (9, 10, 11, 12, 13). Partial trisomy 16q21-qter may be associated with a nonlethal phenotype in some cases (13), but not in all (10, 12). In almost all patients reported with variable phenotypes, the extent of the 16q anomaly has not been precisely delineated. In several patients, other defects are present in addition to the partial trisomy 16 (9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21). It has been suggested that the length of the 16q duplication correlates with clinical phenotype and survival (22); nevertheless, accurate phenotype prediction can only be achieved after precise description of the cytogenetic defect in the affected patients and its correlation with existing genetic and physical maps of chromosome 16. Accordingly, patients with relatively smaller defects involving chromosome 16 duplications are useful in defining chromosomal regions associated with particular phenotypes.
Proximal duplication of 16q has only been reported in four patients, involving various intervals from 16q12 to 16q13 (23, 24); in only one of these patients, however, was fluorescent in situ hybridization (FISH) used for confirmation and mapping of the anomaly (24). There has been no precise molecular genetic mapping of proximal 16q duplications, and only one study confirmed a 16q22-qter duplication by both FISH and polymorphic markers (22).
The patient described in this report, a 22-yr-old female, had a distinct phenotype, with only a few findings in common with those of other patients with 16q anomalies (7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25). Her anisomastia was reminiscent of that of patients with ulnar-mammary syndrome (UMS), a condition that, in addition, affects normal development of the upper extremities (26); however, our patient had no other findings from that syndrome. The abnormality was confirmed by FISH, using as probes clones from available genomic area contigs, and was defined by flanking genetic markers to be not longer than 15.8 centimorgans (cM).
| Subject and Methods |
|---|
|
|
|---|
The patient was a 22-yr-old female (Fig. 1
) with mild to moderate developmental
delay who was referred to our clinic with the diagnosis of possible
Williams-Beuren syndrome (WBS), commonly referred to as Williams
syndrome or infantile hypercalcemia with elfin facies (Mendelian
inheritance in man catalog no. 194050) (27). Her past medical history
included a normal birth and early infancy with developmental delay
becoming evident after the first year of life. At about the same time,
several developmental defects were recognized for the first time, too.
These included dysmorphic facies, dental hypoplasia with small teeth
and large interdental spaces, an enlarged left atrium without any other
heart defects and normal heart function (by echocardiography), an
intensely hoarse voice due to vocal cord soft tissue nodules (without
vocal cord paralysis), a growing umbilical hernia (which was eventually
surgically repaired at the age of 5 yr), gastroesophageal reflux (which
was medically treated), clinodactyly, contractions of the small joints
(fingers and toes), and hyperextensibility of large joints. The patient
had a normal adrenarche (7 yr of age) and menarche (at age 11 yr), with
normal menses thereafter. Breast development was asymmetric, which led
to left breast surgical reduction at age 15 yr. Other chronic problems
included attention deficit disorder (treated medically), recurrent
urinary tract infections (with normal urinary tract anatomy by imaging
studies), constipation, and severe hyperopia requiring bifocal
lenses.
|
Our physical examination revealed a patient with a pleasant, "party-like" personality (which is frequently found in patients with WBS), with a stocky body habitus, slightly overweight (95%), and with a height appropriate for her genetic (midparental) height (1025%). Findings included mildly upslanting palpebral fissures and stellate iris pattern bilaterally; narrow and tortuous ear canals; a beaked nose and anteverted nares; hypoplastic philtrum and a small mouth; a high arched palate and small, widely spaced teeth; a short neck with a low posterior hairline and a mild dorsocervical fat pad; anisomastia (despite the previous surgery) with widely spaced nipples; thin upper and lower extremities with bilateral clinodactyly and contractures of third, fourth, and fifth fingers; anteverted finger- and toenails; hyperextensibility of metacarpal joints; and several skin lentigines and fewer nevi throughout the body. Imaging studies were normal, including sonograms of the heart, kidneys, and pelvis; magnetic resonance imaging of the brain, chest, and abdomen were also normal. Biochemical studies excluded Cushing syndrome and thyroid and gonadal dysfunction; other routine laboratory studies were also normal.
The patient, her mother, and her sister consented to cytogenetic and DNA studies and use of the probands photographs for the purposes of medical education and publication.
Karyotype
High resolution karyotype analysis was obtained by standard methods from the patient, her mother, and her sister. Targeted FISH, using chromosome bands 16q12, 13, 14, 21, 22, 23, and 24 DNAs as probes, was then performed as previously reported (28).
DNA extraction, polymorphic marker analysis and mapping, and karyotype
DNA was extracted from peripheral blood, as previously described
(29). Polymorphic markers of chromosome 16 were tested by PCR after end
labeling with [
-32P]ATP of the reverse
primer for each marker, as previously described (29). The sequences and
genomic order of these primers are available in the genome database on
line (HYPERLINK "http://gdbwww.gdb.org/" http://gdbwww.gdb.org/and
HYPERLINK "http://www-genome.wi.mit.edu/"
http://www-genome.wi.mit.edu) as well as in maps that have been
published previously (30, 31, 32, 33, 34, 35).
For polymorphic marker analysis, equal amounts of DNA from the patient, her mother, and her sister were amplified along with control samples; the specimens were then run on 6% acrylamide gels (Promega Corp., Madison, WI), which were dried and exposed to X-OMAT films (Eastman Kodak Co., Rochester, NY). The autoradiography films were scanned, and the optical density (OD) of the bands was calculated using the NIH 1.611 program, as previously described (36). An increase in OD in patients allelic bands compared to the corresponding alleles in the patients mother and sister and control samples (adjusted for homozygosity or heterozygosity at the given locus) was considered evidence of inclusion of the markers physical locus in the duplicated segment.
Radiation hybrid mapping of the markers that were found to be included
in the duplicated segment (Table 1
) and
were not included in the on-line or published maps was obtained by
standard methods (37) to determine their most likely order on
16q13.
|
FISH was performed with three bacterial artificial chromosomes
(BACs) as probes, in a process that was recently outlined by our
laboratory (38, 39) (Fig. 2
). The BAC
addresses were 7-G-2 (which contains polymorphic marker D16S3117),
571-E-20 (marker D16S3137), 137-F-4 (marker D16S3032), 110-D-9 (marker
D16S408), and 277-I-4 (marker D16S512) in chromosomal order
cen-D16S3117-D16S3137-D16S3032-D16S408-D16S512-tel. All clones were
obtained from a commercially available library (Research Genetics, Inc., Huntsville, AL) after screening for these two
markers by PCR (38, 39). Location, primers, and PCR conditions for
these markers are available on line (see above) or have been published
previously (30, 31, 32, 33, 34, 35).
|
satellite probe labeled with digoxigenin (Oncor, Inc., Gaithersburg,
MD) and detected with fluorescein. Images were obtained with a
Carl Zeiss Axiophot microscope (New York, NY), equipped
with a Cytovision imaging system (Applied Imaging, Pittsburgh, PA), as
previously described (42). | Results |
|---|
|
|
|---|
The patients most important findings are shown in Fig. 1
. There
have been more than 20 patients with partial trisomy of chromosome 16
reported (21); 4 patients had duplications of the proximal 16q area
(23, 24). Failure to thrive, various degrees of lipoatrophy, hypotonia,
and other neurological abnormalities were present in all patients with
partial trisomy 16, but not in our patient and the others with proximal
16q duplication. Anisomastia or other breast abnormalities were not
present in any other patient with chromosome 16 anomalies. Specific
facial dysmorphic changes, such as high arched palate, hypoplastic
philtrum, and/or thin upper lip, were common in all patients with
partial trisomy 16, including the patient of this report. Other
clinical manifestations (anorectal and other intestinal anomalies,
congenital heart and genital defects, and choanal atresia) that have
been reported in most patients with partial trisomy 16 were not present
in our patient. On the other hand, flexion and other anomalies of the
fingers that were not found in 1 patient with distal 16q duplications
(23) are present in our patient (Fig. 1
) and have been described in
most patients with partial trisomy for the entire, proximal, and middle
16q.
Karyotype, FISH, and analysis of chromosome 16 molecular markers
A peripheral blood high resolution karyotype of the patient
revealed additional chromosomal material in the middle of the long arm
of chromosome 16. Chromosome 16q band-specific probes prepared using
microdissection were initially used as FISH probes to delineate the
duplicated region (Fig. 2
), whereas the WSCR probe showed
the expected two signals (data not shown), making the molecular
diagnosis of WBS unlikely (40). The chromosome 16 anomaly was not
present in the karyotype of the patients mother or that of her sister
(data not shown); thus, it was most likely a de novo defect.
A total of 21 polymorphic STSs that map along chromosome 16 were then
used in the patients DNA and that of her mother and sister (Table 1
).
Densitometric analysis showed that D16S400, a marker located at 81.8 cM
from the top of chromosome 16, was likely to be involved in the
duplication. Seven markers proximal to D16S400 by radiation hybrid
mapping were tested in the same panel of DNA samples. Markers D16S3137
(67 cM from the top of chromosome 16), D16S3032 (71 cM), D16S408 (73
cM), and D16S400 (81.8 cM) were included in the duplication, whereas
the two flanking markers (with normal OD) were D16S419 (66 cM) and
D16S421 (84.4 cM), centromeric and telomeric of the duplication,
respectively. Markers D16S415 and D16S503 were uninformative (Table 1
).
The location of the duplication was further confirmed and precisely
mapped by BACs, which were obtained from a commercially available
library, labeled, and used for FISH (Fig. 2
). The BACs containing STSs
D16S408, D16S3137, and D16S3032, markers that correspond to 16q13,
revealed the duplication (Fig. 2
), whereas a BAC containing D16S512,
which corresponds to 16q21-q22, revealed normal chromosome 16 material
(data not shown). The distance between the probe signals suggested a
tandem duplication. The allele analysis of the polymorphic STSs showed
that the duplication was present on the maternally derived chromosome
16.
| Discussion |
|---|
|
|
|---|
UMS is caused by mutations in the TBX3 gene, which has been localized to chromosome 12q23 and is part of a large family of genes with various developmental functions (44). None of the members of the TBX protein family or their functional regulators has been mapped to the 16q11-q21 region (27, 43). Furthermore, anisomastia in patients with UMS, when present, is the result of unilateral breast aplasia or hypoplasia (26, 44); in the patient of this report, anisomastia, like that in the previously reported families (7), was the result of uneven breast growth with absence of other mammary developmental abnormalities. Nevertheless, it is possible that a gene(s) localized on chromosome 16q13 acts in a molecular pathway that involves TBX3 in regulating normal breast development.
It is interesting that none of the other four patients with duplications limited to the 16q11-q13 region had breast abnormalities (23, 24, 45, 46), including a 34-yr-old woman (24). In patients with chromosomal duplications, however, the abnormalities result not only from increased dosage of the involved genetic material, but also from the disruption of a gene(s) localized at the boundaries of the duplicated region. In that sense, each of the described patients is unique, because even though duplicated regions may overlap (which may be the reason behind some clinical similarities), the boundaries of the lesions are almost always different. Given that the size of the involved area in our patient is the smallest reported among all patients with partial trisomy 16, it is more likely that her anisomastia and perhaps most of her other findings are the result of gene(s) disruption rather than increased dosage effect.
What clinical similarities, if any, did our patient have with the other reported patients? The probands small joint contractures have been described in almost all patients with partial trisomy 16, with the exception of those with distal anomalies (23). This suggests the presence of a gene in the 16q13 region that is responsible for the proper formation or function of the small joints of the upper and lower extremities. Interestingly, a 3-yr-old patient has been described with cerebro-oculo-facio-skeletal syndrome and flexure contracture of the joints who had an apparently balanced translocation involving 16q13 [46,XX, t(1;16)(q23;q13)] (45). There are, however, no obvious candidate genes in the database (27, 43) for such a defect.
Some of the patients anomalies, especially the facial features, have been described in other patients with partial trisomy 16 (23, 24, 47) and also in cases of uniparental disomy (UPD) involving chromosome 16 (48, 49). We speculated above that in our patient, haploinsufficiency for disrupted genes could be present. However, the similarities between her and patients with UPD for chromosome 16 suggest that there might be genes on the long arm of this chromosome that are imprinted. If this is the case, gene disruption may lead not only to haploinsufficiency, but also to homozygosity for silenced genes, not unlike the case in patients with UPD for 16.
We have recently reported that familial macromastia may be associated with increased and aberrant expression of the aromatase (P450arom) gene (50). It is unlikely that P450arom or any other endocrine abnormalities are involved in the presentation of the patient of this report, who had a normal hormonal profile (data not shown) and completed a physiological puberty.
In summary, we reported a patient with partial duplication of the long arm of chromosome 16, who shared facial and other features with other patients with partial trisomy 16q, but also had the unique manifestation of pronounced anisomastia. We speculate that a gene with a role in the control of normal breast growth is located in the 16q13 area, in which our patient had a duplication. The information presented in this report may lead to the appropriate linkage or other genetic studies in families and isolated patients with similar clinical manifestations that will identify these genes.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received February 1, 2000.
Revised May 8, 2000.
Accepted May 24, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Fredriksson, M. Hagglund, P. K. Olszewski, O. Stephansson, J. A. Jacobsson, A. M. Olszewska, A. S. Levine, J. Lindblom, and H. B. Schioth The Obesity Gene, FTO, Is of Ancient Origin, Up-Regulated during Food Deprivation and Expressed in Neurons of Feeding-Related Nuclei of the Brain Endocrinology, May 1, 2008; 149(5): 2062 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stratigopoulos, S. L. Padilla, C. A. LeDuc, E. Watson, A. T. Hattersley, M. I. McCarthy, L. M. Zeltser, W. K. Chung, and R. L. Leibel Regulation of Fto/Ftm gene expression in mice and humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1185 - R1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Simon, D. Noack, J. Rae, J. Curnutte, S. Sarraf, V. Kolev, and J. K. Blancato Long Polymerase Chain Reaction-Based Fluorescence in Situ Hybridization Analysis of Female Carriers of X-Linked Chronic Granulomatous Disease Deletions J. Mol. Diagn., May 1, 2005; 7(2): 183 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Stratakis, M. L Turner, A. Lafferty, J. R Toro, S. Hill, J. M Meck, and J. Blancato A syndrome of overgrowth and acromegaloidism with normal growth hormone secretion is associated with chromosome 11 pericentric inversion J. Med. Genet., May 1, 2001; 38(5): 338 - 343. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |